Vytrus Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 25, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	93	16	13	23	-	-
Market Cap Growth	390.99%	29.02%	-46.26%	-	-	-
Enterprise Value	91	16	14	23	-	-
Last Close Price	12.40	2.16	1.86	3.40	-	-
PE Ratio	47.79	15.95	23.17	38.81	-	-
Forward PE	35.34	21.98	11.97	26.21	-	-
PS Ratio	11.54	2.67	2.69	5.24	-	-
PB Ratio	10.48	2.23	2.38	4.94	-	-
P/TBV Ratio	20.69	5.06	7.59	14.68	-	-
P/FCF Ratio	34.55	9.35	16.55	38.78	-	-
P/OCF Ratio	31.53	8.83	13.96	22.90	-	-
EV/Sales Ratio	11.31	2.64	2.91	5.20	-	-
EV/EBITDA Ratio	38.58	13.67	22.96	30.92	-	-
EV/EBIT Ratio	43.46	16.34	33.82	38.42	-	-
EV/FCF Ratio	33.85	9.24	17.93	38.49	-	-
Debt / Equity Ratio	0.16	0.24	0.39	0.21	0.22	0.24
Debt / EBITDA Ratio	0.60	1.51	3.49	1.31	0.94	1.47
Debt / FCF Ratio	0.53	1.02	2.72	1.63	4.09	-
Net Debt / Equity Ratio	-0.21	-0.10	0.18	0.06	-0.08	-0.06
Net Debt / EBITDA Ratio	-0.79	-0.64	1.63	0.35	-0.36	-0.38
Net Debt / FCF Ratio	-0.69	-0.43	1.27	0.43	-1.56	0.71
Asset Turnover	0.68	0.60	0.54	0.59	0.53	0.39
Inventory Turnover	1.53	1.07	0.72	1.02	1.11	0.59
Quick Ratio	2.79	2.60	1.90	0.99	1.92	2.03
Current Ratio	3.08	3.03	2.46	1.33	2.26	2.39
Return on Equity (ROE)	24.85%	16.23%	10.85%	13.44%	11.45%	6.15%
Return on Assets (ROA)	11.04%	6.02%	2.92%	4.99%	3.82%	2.15%
Return on Capital Employed (ROCE)	18.30%	10.00%	4.90%	9.00%	6.40%	3.50%
Earnings Yield	2.09%	6.27%	4.32%	2.58%	-	-
FCF Yield	2.89%	10.70%	6.04%	2.58%	-	-
Buyback Yield / Dilution	-	-11.71%	-	-	-0.43%	0.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.